Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial.

Lawrence A Leiter Stephen C Bain Hiddo J Lambers HeerspinkThomas IdornJohannes F E MannStephen C BainRichard E PratleySøren RasmussenPeter RossingBernt Johan von ScholtenItamar Raznull null

Published in: Diabetes, obesity & metabolism (2020)

In a contemporary type 2 diabetes population, increasing baseline UACR and declining eGFR were linked with higher risks of cardiorenal events and death.

Keyphrases

type diabetes
small cell lung cancer
glycemic control
epidermal growth factor receptor
tyrosine kinase
human health
cardiovascular disease
insulin resistance
metabolic syndrome
risk assessment